Coronavirus: Second Vaccine Approved for Switzerland
15. Januar 2021 – Swissmedic, the Swiss Agency for Therapeutic Products, approved the second Covid-19 vaccine for the Swiss market on 12 January 2021. Moderna’s vaccine, of which the federal government has ordered about 7.5 million doses, is suitable for adults 18 years and older. A first delivery of 200,000 doses will be made to the army pharmacy in the next few days. The latter will distribute the vaccine to the cantons. Together with the vaccine from Pfizer/BioNTech, which Swissmedic approved on 19 December 2020, around half a million vaccine doses will be available in Switzerland in January. First priority will be given to vaccinating those most at risk. Moderna’s vaccine will be delivered to Switzerland in a staggered manner; the first delivery in January 2021 will include approximately 200,000 vaccine doses. By summer, everyone who wants to be vaccinated should be able to do so.
For further information, see here.